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A biopsy of a 40-year-old male was received with 
a history of mass in sinonasal region for the past 
3 months. Tissue was composed of multiple fragments 
measuring 2 cm × 2 cm in aggregate. Histologically, 
the lesional cells were composed of nests of round-to-
oval intermediate-sized epithelioid cells, surrounded 
by thin fibrovascular septae [Figure 1]. Tumor cells had 
indistinct cell membranes and showed moderate amount 
of amphophilic cytoplasm. The nuclei were round with 
clear chromatin and conspicuous nucleoli. No glandular 
or squamous differentiation was noted. Frequent mitotic 
activity was found.
Immunohistochemically, the tumor cells showed strong 
expression for cytokeratin (AE1/AE3) and negative 
expression for p40, and nuclear protein in testis (NUT) 
immunostains. In situ hybridization for Epstein–Barr 
virus-encoded RNA was also negative. In addition, 
there was loss of INI-1 [Figure 1]. The final diagnosis 
was SMARCB1 (INI-1)-deficient poorly differentiated 
carcinoma of sinonasal tract.
The differential diagnoses of poorly differentiated 
carcinomas include basaloid squamous cell carcinoma, 
lymphoepithelial carcinoma, sinonasal undifferentiated 
carcinoma, small cell neuroendocrine carcinoma, poorly 
differentiated non-keratinizing squamous cell carcinoma 
and NUT midline carcinoma. Since the finding of loss of 
INI-1 in poorly differentiated carcinomas of sinonasal 
tract, a new entity has been approved by head and neck 
Figure 1: (a) Poorly differentiated carcinoma showing round-to-oval cells with amphophilic moderate amount of cytoplasm and 
vesicular nuclei with prominent nucleoli, (b) p40 negative, (c) EBER negative, (d) nuclear protein in testis negative, (e) cytokeratin 
positive, (f) INI (SMARCB1) loss with positive internal control
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pathologists, i.e., SMARCB1 (INI-1)-deficient poorly 
differentiated carcinoma of sinonasal tract.[1]
SMARCB1 (INI-1), a tumor suppressor gene, is located 
on long arm of chromosome 22. SMARCB1 mutation has 
been observed in a large group of high-grade neoplasms 
exhibiting rhabdoid morphology.
There are very few cases of SMARCB1 (INI-1)-deficient 
sinonasal carcinomas reported in literature so far.[1,2] The 
majority of patients presented with symptoms including 
epistaxis, headaches, visual disturbances, nasal obstruction 
and facial pain.
Many INI-1-deficient sinonasal carcinomas were initially 
diagnosed as basaloid squamous cell carcinomas based 
on the presence of cohesive basaloid epithelial cells 
surrounded by palisading columnar cells.[3] Differentiating 
undifferentiated sinonasal carcinoma from SMARCB1 
(INI1)-deficient sinonasal carcinoma can be tough as 
both share similar histological traits including large nuclei 
with prominent nucleoli, increased mitotic index, tumor 
necrosis and lack of squamous differentiation.[2]
The presence of rhabdoid cells is the most helpful feature 
that raises the possibility of SMARCB1 (INI-1)-deficient 
sinonasal carcinoma. Using SMARCB1, immunostain 
is a recommended way to recognize this rare entity 
and differentiate it from other poorly differentiated/
undifferentiated sinonasal carcinomas.
Clinical outcomes and importance of INI-1 deficiency 
require long-term follow-up studies in days to come.
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